|
1
|
Young LS and Murray PG: Epstein-Barr virus
and oncogenesis: from latent genes to tumours. Oncogene.
22:5108–5121. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schepers A, Ritzi M, Bousset K, et al:
Human origin recognition complex binds to the region of the latent
origin of DNA replication of Epstein-Barr virus. EMBO J.
20:4588–4602. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sears J, Kolman J, Wahl GM and Aiyar A:
Metaphase chromosome tethering is necessary for the DNA synthesis
and maintenance of oriP plasmids but is insufficient for
transcription activation by Epstein-Barr nuclear antigen 1. J
Virol. 77:11767–11780. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nanbo A, Sugden A and Sugden B: The
coupling of synthesis and partitioning of EBV’s plasmid replicon is
revealed in live cells. EMBO J. 26:4252–4262. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sugden B and Warren N: A promoter of
Epstein-Barr virus that can function during latent infection can be
transactivated by EBNA-1, a viral protein required for viral DNA
replication during latent infection. J Virol. 63:2644–2649.
1989.PubMed/NCBI
|
|
6
|
Altmann M, Pich D, Ruiss R, Wang J, Sugden
B and Hammerschmidt W: Transcriptional activation by EBV nuclear
antigen 1 is essential for the expression of EBV’s transforming
genes. Proc Natl Acad Sci USA. 103:14188–14193. 2006. View Article : Google Scholar
|
|
7
|
Gahn TA and Sugden B: An EBNA-1-dependent
enhancer acts from a distance of 10 kilobase pairs to increase
expression of the Epstein-Barr virus LMP gene. J Virol.
69:2633–2636. 1995.PubMed/NCBI
|
|
8
|
Sample J, Henson EB and Sample C: The
Epstein-Barr virus nuclear protein 1 promoter active in type I
latency is autoregulated. J Virol. 66:4654–4661. 1992.PubMed/NCBI
|
|
9
|
Sung NS, Wilson J, Davenport M, Sista ND
and Pagano JS: Reciprocal regulation of the Epstein-Barr virus
BamHI-F promoter by EBNA-1 and an E2F transcription factor. Mol
Cell Biol. 14:7144–7152. 1994.PubMed/NCBI
|
|
10
|
Frappier L: Role of EBNA1 in NPC
tumourigenesis. Semin Cancer Biol. 22:154–161. 2012. View Article : Google Scholar
|
|
11
|
Westhoff Smith D and Sugden B: Potential
cellular functions of Epstein-Barr nuclear antigen 1 (EBNA1) of
Epstein-Barr virus. Viruses. 5:226–240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kennedy G, Komano J and Sugden B:
Epstein-Barr virus provides a survival factor to Burkitt’s
lymphomas. Proc Natl Acad Sci USA. 100:14269–14274. 2003.
View Article : Google Scholar
|
|
13
|
Holowaty MN, Zeghouf M, Wu H, et al:
Protein profiling with Epstein-Barr nuclear antigen-1 reveals an
interaction with the herpesvirus-associated ubiquitin-specific
protease HAUSP/USP7. J Biol Chem. 278:29987–29994. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Holowaty MN, Sheng Y, Nguyen T, Arrowsmith
C and Frappier L: Protein interaction domains of the
ubiquitin-specific protease, USP7/HAUSP. J Biol Chem.
278:47753–47761. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wilson JB, Bell JL and Levine AJ:
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell
neoplasia in transgenic mice. EMBO J. 15:3117–3126. 1996.PubMed/NCBI
|
|
16
|
Murakami M, Lan K, Subramanian C and
Robertson ES: Epstein-Barr virus nuclear antigen 1 interacts with
Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to
suppress cell migration. J Virol. 79:1559–1568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kaul R, Murakami M, Choudhuri T and
Robertson ES: Epstein-Barr virus latent nuclear antigens can induce
metastasis in a nude mouse model. J Virol. 81:10352–10361. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
O’Neil JD, Owen TJ, Wood VH, et al:
Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription
factor pathway in nasopharyngeal carcinoma cells and enhances
angiogenesis in vitro. J Gen Virol. 89:2833–2842. 2008. View Article : Google Scholar
|
|
19
|
Wood VH, O’Neil JD, Wei W, Stewart SE,
Dawson CW and Young LS: Epstein-Barr virus-encoded EBNA1 regulates
cellular gene transcription and modulates the STAT1 and TGFbeta
signaling pathways. Oncogene. 26:4135–4147. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Flavell JR, Baumforth KR, Wood VH, et al:
Down-regulation of the TGF-beta target gene, PTPRK, by the
Epstein-Barr virus encoded EBNA1 contributes to the growth and
survival of Hodgkin lymphoma cells. Blood. 111:292–301. 2008.
View Article : Google Scholar
|
|
21
|
Valentine R, Dawson CW, Hu C, et al:
Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB
pathway in carcinoma cells by inhibiting IKK phosphorylation. Mol
Cancer. 9:12010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gruhne B, Sompallae R, Marescotti D,
Kamranvar SA, Gastaldello S and Masucci MG: The Epstein-Barr virus
nuclear antigen-1 promotes genomic instability via induction of
reactive oxygen species. Proc Natl Acad Sci USA. 106:2313–2318.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gruhne B, Sompallae R and Masucci MG:
Three Epstein-Barr virus latency proteins independently promote
genomic instability by inducing DNA damage, inhibiting DNA repair
and inactivating cell cycle checkpoints. Oncogene. 28:3997–4008.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hennessy K and Kieff E: One of two
Epstein-Barr virus nuclear antigens contains a glycine-alanine
copolymer domain. Proc Natl Acad Sci USA. 80:5665–5669. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hennessy K, Heller M, van Santen V and
Kieff E: Simple repeat array in Epstein-Barr virus DNA encodes part
of the Epstein-Barr nuclear antigen. Science. 220:1396–1398. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Allday MJ and MacGillivray AJ:
Epstein-Barr virus nuclear antigen (EBNA): size polymorphism of
EBNA 1. J Gen Virol. 66:1595–1600. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Levitskaya J, Coram M, Levitsky V, et al:
Inhibition of antigen processing by the internal repeat region of
the Epstein-Barr virus nuclear antigen-1. Nature. 375:685–688.
1995. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Snudden DK, Smith PR, Lai D, Ng MH and
Griffin BE: Alterations in the structure of the EBV nuclear
antigen, EBNA1, in epithelial cell tumours. Oncogene. 10:1545–1552.
1995.PubMed/NCBI
|
|
29
|
Chang CM, Yu KJ, Mbulaiteye SM, Hildesheim
A and Bhatia K: The extent of genetic diversity of Epstein-Barr
virus and its geographic and disease patterns: a need for
reappraisal. Virus Res. 143:209–221. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gutiérrez MI, Raj A, Spangler G, et al:
Sequence variations in EBNA-1 may dictate restriction of tissue
distribution of Epstein-Barr virus in normal and tumour cells. J
Gen Virol. 78:1663–1670. 1997.PubMed/NCBI
|
|
31
|
Sandvej K, Zhou XG and Hamilton-Dutoit S:
EBNA-1 sequence variation in Danish and Chinese EBV-associated
tumours: evidence for geographical polymorphism but not for
tumour-specific subtype restriction. J Pathol. 191:127–131. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang JT, Sheeng TS, Su IJ, Chen JY and
Chen MR: EBNA-1 sequence variations reflect active EBV replication
and disease status or quiescent latency in lymphocytes. J Med
Virol. 69:417–425. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Do NV, Ingemar E, Phi PT, et al: A major
EBNA1 variant from Asian EBV isolates shows enhanced
transcriptional activity compared to prototype B95.8. Virus Res.
132:15–24. 2008. View Article : Google Scholar
|
|
34
|
Habeshaw G, Yao QY, Bell AI, Morton D and
Rickinson AB: Epstein-Barr virus nuclear antigen 1 sequences in
endemic and sporadic Burkitt’s lymphoma reflect virus strains
prevalent in different geographic areas. J Virol. 73:965–975.
1999.PubMed/NCBI
|
|
35
|
Mai SJ, Xie D, Huang YF, et al: The
enhanced transcriptional activity of the V-val subtype of
Epstein-Barr virus nuclear antigen 1 in epithelial cell lines.
Oncol Rep. 23:1417–1424. 2010.PubMed/NCBI
|
|
36
|
Zhang XS, Wang HH, Hu LF, et al: V-val
subtype of Epstein-Barr virus nuclear antigen 1 preferentially
exists in biopsies of nasopharyngeal carcinoma. Cancer Lett.
211:11–18. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang WY, Chien YC, Jan JS, Chueh CM and
Lin JC: Consistent sequence variation of Epstein-Barr virus nuclear
antigen 1 in primary tumor and peripheral blood cells of patients
with nasopharyngeal carcinoma. Clin Cancer Res. 8:2586–2590.
2002.PubMed/NCBI
|
|
38
|
Chang YS, Shih LY, Peng CL, Chen SH and
Liu ST: Characterization of two newly established EBV-containing
lymphoblastoid cell lines from patients with myeloid leukemias.
Leuk Res. 14:309–320. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Miller G, Shope T, Lisco H, Stitt D and
Lipman M: Epstein-Barr virus: transformation, cytopathic changes,
and viral antigens in squirrel monkey and marmoset leukocytes. Proc
Natl Acad Sci USA. 69:383–387. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pulvertaft JV: A study of malignant
tumours in Nigeria by shortterm tissue culture. J Clin Pathol.
18:261–273. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hinuma Y and Grace JT Jr: Cloning of
immunoglobulin-producing human leukemic and lymphoma cells in
long-term cultures. Proc Soc Exp Biol Med. 124:107–111. 1967.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Arrand JR, Walsh-Arrand JE and Rymo L:
Cytoplasmic RNA from normal and malignant human cells shows
homology to the DNAs of Epstein-Barr virus and human adenoviruses.
EMBO J. 2:1673–1683. 1983.PubMed/NCBI
|
|
43
|
Graham FL, Smiley J, Russell WC and Nairn
R: Characteristics of a human cell line transformed by DNA from
human adenovirus type 5. J Gen Virol. 36:59–74. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Baer R, Bankier AT, Biggin MD, et al: DNA
sequence and expression of the B95-8 Epstein-Barr virus genome.
Nature. 310:207–211. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang TC and Chao M: Molecular cloning and
expression of the hepatitis delta virus genotype IIb genome.
Biochem Biophys Res Commun. 303:357–363. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bhatia K, Raj A, Guitierrez MI, et al:
Variation in the sequence of Epstein-Barr virus nuclear antigen 1
in normal peripheral blood lymphocytes and in Burkitt’s lymphomas.
Oncogene. 13:177–181. 1996.PubMed/NCBI
|
|
47
|
Chen MR, Tsai CH, Wu FF, Kan SH, Yang CS
and Chen JY: The major immunogenic epitopes of Epstein-Barr virus
(EBV) nuclear antigen 1 are encoded by sequence domains which vary
among nasopharyngeal carcinoma biopsies and EBV-associated cell
lines. J Gen Virol. 80:447–455. 1999.PubMed/NCBI
|
|
48
|
Niedobitek G: Epstein-Barr virus infection
in the pathogenesis of nasopharyngeal carcinoma. Mol Pathol.
53:248–254. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mai SJ, Ooka T, Li DJ, et al: Functional
advantage of NPC-related V-val subtype of Epstein-Barr virus
nuclear antigen 1 compared with prototype in epithelial cell line.
Oncol Rep. 17:141–146. 2007.
|
|
50
|
de Thé G: Nasopharyngeal carcinoma. Viral
Infections of Humans, Epidemiology and Control. Evans AS and
Kazslow RA: 4th edition. Plenum Medical Book Co; New York, NY: pp.
935–967. 1997, View Article : Google Scholar
|
